Cardiopulmonary exercise testing (CPEX) is a valuable clinical tool that has proven indications within the fields of cardiovascular, respiratory and pre-operative medical care. Validated uses include investigation of the underlying mechanism in patients with breathlessness, monitoring functional status in patients with known cardiovascular disease and pre-operative functional state assessment. An understanding of the underlying physiology of exercise, and the perturbations associated with pathological states, is essential for healthcare professionals to provide optimal patient care. Healthcare professionals may find performing CPEX to be daunting, yet this is often due to a lack of local expertise and guidance with testing. We outline the indications for CPEX within the clinical setting, present a typical protocol that is easy to implement, explain the key underlying physiological changes assessed by CPEX, and review the evidence behind its use in routine clinical practice. There is mounting evidence for the use of CPEX clinically, and an ever-growing utilisation of the test within research fields; a sound knowledge of CPEX is essential for healthcare professionals involved in routine patient care.
Introduction
Cardio-pulmonary exercise (CPEX) testing is used to establish the degree of exercise limitation, to identify the underlying mechanisms responsible in patients with breathlessness, and to monitor functional status in cardiovascular disease (1) . It is an important prognostic tool and decision-aid in the assessment of perioperative risk (2) . In addition to the routine parameters measured during the exercise electrocardiogram (ECG) stress test, CPEX can provide measurements of oxygen (O2) consumption, carbon dioxide (CO2) production, and lung ventilation to provide valuable information about respiratory, cardiovascular and muscle metabolic function as well as the subject's effort during the test. Despite its useful diagnostic and prognostic functions, and established role in several guidelines for management of cardiovascular diseases, CPEX has remained largely a research or sport sciences tool, and is grossly under-utilized in clinical practice. This is commonly due to a lack of local expertise or awareness about the utility of CPEX among physicians. We review the indications and contraindications for CPEX and describe a standard protocol for cardiopulmonary stress testing. Additionally, we propose a practical reporting and data interpretation guide for the junior cardiology/respiratory trainee.
Indications and contraindications of CPEX
The diagnostic and prognostic indications, along with the contraindications for CPEX testing are listed in Table 1 . The ATS/ACCP guidelines (2003) include these absolute contraindications to CPEX (3) , however recently the test has been performed safely in conditions like severe aortic stenosis (4) . Indications to perform the test are also increasing, as in the diagnosis of heart failure with normal ejection fraction (5) and in exercise prescription for heart failure patients (6). 
Preparation for CPEX Assessment
Patients are advised to avoid caffeine, nicotine and food for two hours prior to CPEX (7).
Enquiry into the patient's past medical history, medications, any limitations and any special requirements for participation in CPEX should be made. If the patient has a pacemaker, defibrillator or a cardiac resynchronisation device, guidance of the cardiac physiologist or rhythm management specialist should be sought. Additional assessments which should be completed in advance of CPEX include: clinical examination of the cardiovascular, respiratory and peripheral vascular systems, ECG, resting oxygen saturation, blood pressure (BP), spirometry, including vital capacity and forced expiratory volume in the first second (FEV1).Commonly used abbreviations in CPEX are given in table 2. 
Protocol
The patient is prepared by connecting them to an ECG monitor and facemask. The facemask is tested for any air-leak and connected to the gas analyser. An alternative to facemask is mouthpiece with a nose-clip. Saliva dribbling from the mouthpiece is however a problem especially at peak exercise. A pulse oximeter and sphygmomanometer are attached. Oxygen saturation could be measured either through a finger or earlobe probe (3). New forehead sensors are another alternative.
Incremental exercise testing can either be performed on a treadmill or an electronically-braked cycle. Treadmills are widely used in USA and UK (9), and are a popular method allowing most patients to exercise to their maximal physical limit, achieving satisfactory end-points.
Cycle ergometers are advantageous for quantifying work-rate accurately and additionally enable clinicians to gain arterial blood gas (ABG) samples if necessary. People with musculoskeletal limitations or imbalance that might limit weight-bearing may prefer the cycle ergometer, however hamstring fatigue could stop cycle exercise before true peak VO2 is reached (9). The peak VO2 achieved on cycle is usually 10-20% lower than that on a treadmill (9) . Figure 1 shows a patient performing CPEX on a cycle ergometer. Current software calculates the maximum watts achievable automatically, based on the patient's sex, age, height, and weight. Then a protocol is selected to reach the maximum exercise in 10-minutes, usually by dividing likely maximum watts by 10. The patient should be encouraged to exercise to his/her maximum physical limit, so that O2 consumption at peak exercise can be measured.
Several protocols with different increments in workload exist; a typical example is presented in Table 3 . Following a 2-minute warm-up period, the exercise starts with speed and gradient increased by 1 km/hour and 1% respectively every minute. Less fit patients can use a protocol with half a kilometre speed increase every minute. The operator records the reason for stopping the test at the end. Patients should be monitored closely for complications. Table 4 lists the indications for terminating the test early. Oxygen (O2) consumption and carbon dioxide (CO2) production increase with incremental workload on exercise. CO2 production is linearly related to the amount of O2 consumed during exercise, until the onset of anaerobic metabolism (3). The lactate produced by anaerobic metabolism contributes to additional CO2 production, measured in the expired air from this time point, resulting in a disproportionate increase in CO2. This inflection point between the linear component and the progressively greater increase in CO2 production relative to the O2 consumption is called the anaerobic threshold (10) . An example is shown in figure 3 .
Peak and Max VO2
O2 consumption obtained at peak exercise (averaged over 60 seconds) is called peak VO2 (PVO2). A peak VO2 <85% of that predicted for age and gender, indicates significant exercise limitation (3). Normal age and sex specific values for Peak VO2 have been defined in various studies (11, 12) . At maximal exercise, the VO2 consumption plateaus despite incremental increases in workload. This state is achievable in healthy adults (13) . Max VO2 is a term used to denote the maximum O2 consumption possible for that subject, and is measured by several When ventilation (VE on Y axis) is plotted against carbon dioxide (VCO2 on the X axis), the relationship is linear until the anaerobic threshold is reached, with a slope of 23-28 degrees.
The relationship is steeper in conditions associated with increased VD/VT ratio such as heart failure, pulmonary vascular disease, interstitial lung disease and COPD, while it is normal in patients with exercise limitation due to deconditioning (3, 19) . The slope is measured from the beginning of exercise to just after the anaerobic threshold, as shown in figure 2 . The VE/VCO2 slope increases with age in normal subjects. A value of <30 degrees is considered normal. 
Analysis and interpretation
A peak VO2 of <85% predicted (for age and gender) indicates significant exercise limitation (3).
Respiratory Exchange ratio
Respiratory Exchange Ratio (RER or simply R) is the ratio of the CO2 production to O2 consumption (RER=VCO2/VO2). Once anaerobic metabolism begins, RER progressively increases. A RER of >1.15 at peak exercise indicates an adequate exercise test (3). Current software measures RER automatically and is displayed throughout the test.
Anaerobic threshold measurement
Anaerobic threshold can be identified from several scatter graphs obtained by automatic software by plotting gas exchange markers against each other. The V-slope method, where the VCO2 is plotted against VO2 is the preferred method (see Figure 3 ). Other graphs used for determining the anaerobic threshold are VO2, VCO2 against time (see Figure 4) , VE/VCO2, VE/VO2 against time, and PETCO2, PETO2 against time. Normal individuals exhaust their cardiovascular potential at peak exercise. Their breathing reserve is preserved (>11L) at peak exercise, indicating that the limitation to further exercise is the cardiovascular system (3). One exception to this are athletes who have excellent cardiovascular fitness; they can deplete their breathing reserve at peak exercise to <11 L, but achieve a supra-normal peak VO2 (22).
Deconditioning
A low peak VO2, normal VE/VCO2 slope, normal VO2 at anaerobic threshold, and preserved breathing reserve indicate deconditioning (3). A simplified diagnostic approach is shown in Figure 6 . 
Evidence base
Heart Failure CPEX is a cornerstone test in identifying heart failure patients for heart transplantation; a peak VO2<14 mL/kg/min in patients not on beta-blockers and peak VO2<12 mL/kg/min in patients on beta-blockers is the current recommendation for consideration for heart transplantation (23) (24) (25) .
VE/VCO2 slope is another predictor of mortality in heart failure patients. Gitt et al showed a low VO2 at anaerobic threshold (AT) of <11 mL/kg/min and a high VE/VCO2 slope of >34 degrees at AT were strong predictors of 6 month prognosis in heart failure patients (26) .
However, the VE/VCO2 slope is yet to find a place in cardiac transplant guidelines.
Lung resection
In the case of lung tumour resection surgery, Beckles' et al review of the literature (27) showed lung cancer patients with:
1. Peak VO2 of >20 were not at increased risk of complications 2. Peak VO2 of <15 were at increased risk of post-operative complications 3. Peak VO2 of <10 were at very high risk of peri-operative complications CPEX is not necessary in all patients undergoing lung resection, but to risk-stratify patients with an FEV1 or diffusion capacity <80% of predicted on pre-operative testing (28) .
Abdominal surgery CPEX is increasingly used for risk stratification in patients with known cardiovascular and respiratory disease being considered for major non-cardiac surgery. Current evidence is:
1. VO2 at AT of >11 mL/kg/min combined with a VE/VCO2 slope of <35 are predictors for low cardio-vascular risk after major abdominal surgery (29, 30 ).
A VO2 at AT of >11 mL/kg/min is correlated with improved post-operative survival in open
and endo-vascular aortic surgery (31). Nagamatsu et al showed that in patients undergoing oesophagectomy, a low peak VO2 was associated with increased cardiovascular complications (32) . They concluded that a peak VO2 of <800 ml/m2 is associated with a higher risk.
Reporting
A standard reporting format includes pre-test observations, test findings and interpretation. An example is given below. In our department, an experienced cardiologist reports all CPEX's.
An accurate interpretation of the test should be made available within 72 hours; this ought to be earlier if the findings are significantly abnormal (33) . A sample reporting tool is shown in (34) . The physician in-charge of the exercise laboratory decides on the appropriateness of the request for testing, and the degree of supervision needed depending on the specific clinical situation. In patients who have had a recent AMI (7-10 days), severe valvular stenosis, or complex arrhythmias, direct physician supervision is indicated (35) . In most other cases appropriately trained physiologists and specialist nurses can conduct the test safely, with the physician in the immediate vicinity. Two people are required to conduct the test, both qualified in cardio-pulmonary resuscitation (36) . Blood pressure should be measured every 2-3 minutes and more frequently in high risk patients (13) . Continuous ECG monitoring is mandatory during the test and should be continued 6 minutes into recovery (13) .Manual measurement of blood pressure is still the preferred method during stress test (34) . Staff performing the test should be aware of the indications for exercise test and be able to recognise adverse events (13) .
The AHA guidelines (2000) recommend that a physician in-charge should have participated in 50 procedures over a dedicated 4 week period to achieve competence in supervision and reporting of exercise tests, and should continue to perform 25 cases per year to preserve competence (35) . The physician is responsible for data interpretation and suggesting further evaluation and testing (33) . The physician should also maintain advanced cardiovascular life support competence. The AHA guidelines detail the cognitive skills required for performing and interpreting the test (35) .
The exercise laboratory should be a spacious room and have the necessary equipment for advanced cardiac life support. Each laboratory should have a written emergency plan and all personnel should rehearse it on a regular basis (36) . Written informed consent is required prior to the exercise test (9) .
Conclusion
CPEX testing is a relatively safe non-invasive tool which provides excellent diagnostic and prognostic information in patients with heart or lung disease. It should be utilized as a complementary diagnostic tool in the investigation of breathless patients, along with chest Xray, echocardiography, pulmonary angiography, right heart catheterisation, and coronary angiography.
It is increasingly used in pre-operative risk assessment, cardiac and pulmonary rehabilitation, and adult congenital heart disease. With increasing applications and understanding, a sound grasp of the nuances of CPEX testing is mandatory for the cardiac, pulmonary and general physician.
